Board Advisor

Abraham Hulsebos

A serial entrepreneur since a young age with deep experience across IT, telecommunications, trade, and logistics. Specialized in legal strategy, corporate structuring, and financial management, with a strong track record developing innovative business concepts — several of which were later adopted and integrated by Apple. Actively involved in multiple IPOs on both Euronext and Nasdaq, and a former board member of leading international IT companies including Electronic Data Systems. Deeply engaged in the evolution of the internet and emerging digital technologies.

Board Advisor

Pieter Vermeer

An experienced entrepreneur across information technology and the construction sector. Pieter has built several successful companies with multiple exits to large listed enterprises. He is co-founder of Synergia Capital Partners B.V. (1999) and orchestrated the merger at the family business Dura Vermeer Groep — one of the largest construction companies in the Netherlands with €2.4B turnover and 4,000 employees. He is co-founder and CEO of Qonnected Logistics.

Board Advisor

Vishal

Vishal is a serial investor, entrepreneur, and strategic advisor known for his ability to identify emerging opportunities and help businesses accelerate growth. With deep expertise in stakeholder engagement, governance, and strategic positioning, he has built a reputation for aligning vision with execution across multiple ventures. His extensive network, investment acumen, and growth-oriented mindset provide CDS with valuable guidance as the company continues to expand its market presence and long-term impact.

Board Advisor

Dr. Senthil Kumaran

Dr. Senthil Kumaran FRCA is a distinguished healthcare leader, AI safety expert, and strategic advisor with over 30 years of experience in clinical practice, healthcare innovation, and regulatory oversight. Having served in senior leadership roles within the UK's National Health Service, he combines deep medical expertise with a strong understanding of digital health transformation, clinical risk assessment, and healthcare compliance. His ability to bridge the gap between clinical realities and emerging technologies provides CDS with critical guidance in innovation strategy, governance, and the responsible adoption of AI-driven solutions.